Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor M Bolton

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Transplantation|March 24, 2005
Regulatory T cells in transplantation: natural or induced?Eleanor M Bolton
Regenerative Medicine|May 2, 2015
Avoiding immunological rejection in regenerative medicineEleanor M Bolton, John Andrew Bradley
Transplantation|March 20, 2009
Antiplatelet therapy in transplantation: new tricks from old drugs?Kourosh Saeb-Parsy, Eleanor M Bolton
Transplantation|February 28, 2008
Lymphoid tissue formation in allografts: innocent until proven guiltyReza Motallebzadeh, Eleanor M Bolton, Gavin J Pettigrew
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Targeting IL-15 as a therapeutic strategy in organ transplant rejectionXin G Smith, Eleanor M Bolton, J Andrew Bradley
Immunogenetics|July 25, 2003
Complementary DNA sequences encoding the rat MHC class II RT1-Bu and RT1-Du alpha and beta chainsAlistair J Easterfield, J Andrew Bradley, Eleanor M Bolton
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 6, 2011
Immunological considerations for embryonic and induced pluripotent stem cell bankingCraig J Taylor, Eleanor M Bolton, J Andrew Bradley
Transplantation|March 14, 2008
Indirect allorecognition: not simple but effectiveEleanor M Bolton, J Andrew Bradley, Gavin J Pettigrew
Nature Reviews. Immunology|November 5, 2002
Stem cell medicine encounters the immune systemJ Andrew Bradley, Eleanor M Bolton, Roger A Pedersen
Transplant Immunology|October 11, 2003
CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatmentDavid Stell, Hilary Marshall, J Andrew Bradley, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Transplantation|March 24, 2005
Regulatory T cells in transplantation: natural or induced?Eleanor M Bolton
Regenerative Medicine|May 2, 2015
Avoiding immunological rejection in regenerative medicineEleanor M Bolton, John Andrew Bradley
Transplantation|March 20, 2009
Antiplatelet therapy in transplantation: new tricks from old drugs?Kourosh Saeb-Parsy, Eleanor M Bolton
Transplantation|February 28, 2008
Lymphoid tissue formation in allografts: innocent until proven guiltyReza Motallebzadeh, Eleanor M Bolton, Gavin J Pettigrew
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Targeting IL-15 as a therapeutic strategy in organ transplant rejectionXin G Smith, Eleanor M Bolton, J Andrew Bradley
Immunogenetics|July 25, 2003
Complementary DNA sequences encoding the rat MHC class II RT1-Bu and RT1-Du alpha and beta chainsAlistair J Easterfield, J Andrew Bradley, Eleanor M Bolton
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 6, 2011
Immunological considerations for embryonic and induced pluripotent stem cell bankingCraig J Taylor, Eleanor M Bolton, J Andrew Bradley
Transplantation|March 14, 2008
Indirect allorecognition: not simple but effectiveEleanor M Bolton, J Andrew Bradley, Gavin J Pettigrew
Nature Reviews. Immunology|November 5, 2002
Stem cell medicine encounters the immune systemJ Andrew Bradley, Eleanor M Bolton, Roger A Pedersen
Transplant Immunology|October 11, 2003
CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatmentDavid Stell, Hilary Marshall, J Andrew Bradley, et al.
Pageof 4